Pharmacology of the Porphyrins and Porphobilinogen

Overview

Journal Br J Pharmacol Chemother

Specialty Pharmacology

Date 1954 Mar 1

PMID 13149782

Citations 11

Authors

A GOLDBERG

W D Paton

J W Thompson

Affiliations

Soon will be listed here.

Citing Articles

Fate of porphobilinogen, administered enterally or parenterally, in the rat.

GOLDBERG A Biochem J. 1955; 59(1):37-44.

PMID: 14351137 PMC: 1216084. DOI: 10.1042/bj0590037.

[Clinical and pathologico-anatomical manifestations of acute intermittent porphyria].

KREINDLER A, POILICI I, IONASESCU V, Appel E Dtsch Z Nervenheilkd. 1963; 185:20-36.

PMID: 14035675

A survey of some hereditary metabolic diseases.

Watts R Postgrad Med J. 1960; 36:486-97.

PMID: 13843180 PMC: 2481649. DOI: 10.1136/pgmj.36.418.486.

[New data on porphyrin metabolism and porphyrin diseases].

STICH W Klin Wochenschr. 1959; 37(13):681-92.

PMID: 13673548 DOI: 10.1007/BF01478216.

What happens in lead poisoning?.

Lee W J R Coll Physicians Lond. 1981; 15(1):48-54.

PMID: 7463387 PMC: 5377630.

References

Wehrmacher W . New symptomatic treatment for acute intermittent porphyria. AMA Arch Intern Med. 1952; 89(1):111-4. DOI: 10.1001/archinte.1952.00240010121012. View

WESTALL R . Isolation of porphobilinogen from the urine of a patient with acute porphyria. Nature. 1952; 170(4328):614-6. DOI: 10.1038/170614a0. View

Supniewski J . The action of visible light on the haematoporphyrin sensitised organs. J Physiol. 1927; 64(1):30-8. PMC: 1514969. DOI: 10.1113/jphysiol.1927.sp002416. View

FALK J, DRESEL E, Rimington C . Porphobilinogen as a porphyrin precursor, and interconversion of porphyrins, in a tissue system. Nature. 1953; 172(4372):292-4. DOI: 10.1038/172292a0. View

Prunty F . Acute porphyria: Some properties of porphobilinogen. Biochem J. 1945; 39(5):446-51. PMC: 1258263. DOI: 10.1042/bj0390446. View